284 related articles for article (PubMed ID: 12154064)
1. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors.
Paz MF; Avila S; Fraga MF; Pollan M; Capella G; Peinado MA; Sanchez-Cespedes M; Herman JG; Esteller M
Cancer Res; 2002 Aug; 62(15):4519-24. PubMed ID: 12154064
[TBL] [Abstract][Full Text] [Related]
2. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer.
Li SY; Rong M; Iacopetta B
Oncol Rep; 2006 Jan; 15(1):221-5. PubMed ID: 16328059
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer.
Kang S; Kim JW; Kang GH; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2005 Jan; 96(1):173-80. PubMed ID: 15589597
[TBL] [Abstract][Full Text] [Related]
4. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M
Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
[TBL] [Abstract][Full Text] [Related]
5. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa.
Iacopetta B; Grieu F; Phillips M; Ruszkiewicz A; Moore J; Minamoto T; Kawakami K
Cancer Sci; 2007 Sep; 98(9):1454-60. PubMed ID: 17640302
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation profile of kidney cancer.
Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
[TBL] [Abstract][Full Text] [Related]
7. A systematic profile of DNA methylation in human cancer cell lines.
Paz MF; Fraga MF; Avila S; Guo M; Pollan M; Herman JG; Esteller M
Cancer Res; 2003 Mar; 63(5):1114-21. PubMed ID: 12615730
[TBL] [Abstract][Full Text] [Related]
8. Genetic basis of neural tube defects. II. Genes correlated with folate and methionine metabolism.
Gos M; Szpecht-Potocka A
J Appl Genet; 2002; 43(4):511-24. PubMed ID: 12441636
[TBL] [Abstract][Full Text] [Related]
9. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer.
Beetstra S; Suthers G; Dhillon V; Salisbury C; Turner J; Altree M; McKinnon R; Fenech M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2565-71. PubMed ID: 18842997
[TBL] [Abstract][Full Text] [Related]
10. The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase.
Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Watanabe G; Iacopetta B
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5860-5. PubMed ID: 14676107
[TBL] [Abstract][Full Text] [Related]
11. Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers.
Pepe C; Guidugli L; Sensi E; Aretini P; D'Andrea E; Montagna M; Manoukian S; Ottini L; Radice P; Viel A; Bevilacqua G; Caligo MA
Breast Cancer Res Treat; 2007 May; 103(1):29-36. PubMed ID: 17151928
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung.
Kim YT; Park SJ; Lee SH; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1378. PubMed ID: 16256792
[TBL] [Abstract][Full Text] [Related]
13. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours.
Esteller M; Herman JG
J Pathol; 2002 Jan; 196(1):1-7. PubMed ID: 11748635
[TBL] [Abstract][Full Text] [Related]
14. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine and ischaemic heart disease.
Law MR; Wald NJ
Haematologica; 1999 Jun; 84 Suppl EHA-4():57-60. PubMed ID: 10907469
[No Abstract] [Full Text] [Related]
16. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.
Cadieux B; Ching TT; VandenBerg SR; Costello JF
Cancer Res; 2006 Sep; 66(17):8469-76. PubMed ID: 16951158
[TBL] [Abstract][Full Text] [Related]
18. Genetic basis of hyperhomocysteinemia.
Medina MA; Amores-Sánchez MI
Mol Genet Metab; 2000 Nov; 71(3):478-80. PubMed ID: 11073715
[No Abstract] [Full Text] [Related]
19. Influence of folate status on genomic DNA methylation in colonic mucosa of subjects without colorectal adenoma or cancer.
Pufulete M; Al-Ghnaniem R; Rennie JA; Appleby P; Harris N; Gout S; Emery PW; Sanders TA
Br J Cancer; 2005 Mar; 92(5):838-42. PubMed ID: 15726099
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
